T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.69% |
| 2 | Consumer Discretionary | 15.01% |
| 3 | Financials | 13.64% |
| 4 | Technology | 12.55% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRCO
351
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $244M | 0.05% |
6,349,658
+1,287,670
| +25% | +$43.4M |
|
352
Western Alliance Bancorporation
WAL
$8.92B
| $243M | 0.05% |
7,293,551
-12,190
| -0.2% | -$381K |
|
353
Honeywell
HON
$74.2B
| $242M | 0.05% |
2,398,957
-396,806
| -14% | -$37.2M |
|
354
Vipshop
VIPS
$6.8B
| $239M | 0.05% |
18,535,368
-5,198,285
| -22% | -$65.2M |
|
355
3M
MMM
$94.2B
| $237M | 0.05% |
1,704,203
+10,692
| +0.6% | +$1.37M |
|
356
Quest Diagnostics
DGX
$26.1B
| $237M | 0.05% |
3,313,874
+189,868
| +6% | +$12.7M |
|
357
RBC Bearings
RBC
$17.5B
| $235M | 0.05% |
3,203,161
+244,230
| +8% | +$15.5M |
|
358
First American
FAF
$7.56B
| $231M | 0.05% |
6,054,306
-2,114,180
| -26% | -$75.3M |
|
359
SLB Ltd
SLB
$77.3B
| $230M | 0.05% |
3,121,331
-139,554
| -4% | -$9.81M |
|
|
HR
360
DELISTED
Healthcare Realty Trust Incorporated
HR
| $229M | 0.05% |
7,404,373
+960,643
| +15% | +$27.9M |
|
361
CNA Financial
CNA
$13.8B
| $228M | 0.05% |
7,084,545
+800,807
| +13% | +$25.2M |
|
362
Mercado Libre
MELI
$92.7B
| $227M | 0.05% |
1,928,870
-37,813
| -2% | -$3.92M |
|
|
IMS
363
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
| $227M | 0.05% |
8,552,120
+117,167
| +1% | +$2.91M |
|
364
Camden Property Trust
CPT
$11.1B
| $227M | 0.05% |
2,696,461
+270,837
| +11% | +$20.7M |
|
365
Halliburton
HAL
$27.4B
| $226M | 0.05% |
6,334,028
+275,642
| +5% | +$8.99M |
|
366
Valmont Industries
VMI
$9.5B
| $225M | 0.05% |
1,820,110
+292,571
| +19% | +$32.5M |
|
367
Kilroy Realty
KRC
$4.3B
| $225M | 0.05% |
3,639,850
+51,157
| +1% | +$2.87M |
|
368
RH
RH
$3.4B
| $225M | 0.05% |
5,366,288
+737,660
| +16% | +$37.7M |
|
369
Kraft Heinz
KHC
$30.1B
| $224M | 0.05% |
2,851,471
+1,379,588
| +94% | +$103M |
|
370
Acadia Pharmaceuticals
ACAD
$4.89B
| $223M | 0.05% |
7,990,317
+2,395,602
| +43% | +$52.2M |
|
371
Lumen
LUMN
$6.6B
| $222M | 0.05% |
6,941,895
-413,587
| -6% | -$11.6M |
|
|
JBTM
372
JBT Marel
JBTM
$6.1B
| $221M | 0.05% |
3,924,301
+283,700
| +8% | +$13.8M |
|
373
American International
AIG
$39.8B
| $221M | 0.05% |
4,087,067
-191,737
| -4% | -$10.4M |
|
|
WRK
374
DELISTED
WestRock Company
WRK
| $221M | 0.05% |
6,275,584
+2,373,571
| +61% | +$77.3M |
|
375
Diamondback Energy
FANG
$55.9B
| $220M | 0.05% |
2,852,229
-301,655
| -10% | -$21.3M |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.